iHuman Statistics
Share Statistics
iHuman has 4.54M
shares outstanding. The number of shares has increased by -1.22%
in one year.
| Shares Outstanding | 4.54M |
| Shares Change (YoY) | -1.22% |
| Shares Change (QoQ) | -0.39% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 1,764 |
| FTD / Avg. Volume | 2.16% |
Short Selling Information
The latest short interest is 1.51K, so 0% of the outstanding
shares have been sold short.
| Short Interest | 1.51K |
| Short % of Shares Out | n/a |
| Short % of Float | 0.01% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is 6.54 and the forward
PE ratio is null.
iHuman's PEG ratio is
-0.15.
| PE Ratio | 6.54 |
| Forward PE | n/a |
| PS Ratio | 0.7 |
| Forward PS | 0 |
| PB Ratio | 0.67 |
| P/FCF Ratio | 12.62 |
| PEG Ratio | -0.15 |
Financial Ratio HistoryEnterprise Valuation
iHuman has an Enterprise Value (EV) of 2.12B.
| EV / Sales | 2.29 |
| EV / EBITDA | 24.73 |
| EV / EBIT | 36.15 |
| EV / FCF | 41.41 |
Financial Position
The company has a current ratio of 2.98,
with a Debt / Equity ratio of 0.02.
| Current Ratio | 2.98 |
| Quick Ratio | 2.93 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.17 |
| Debt / FCF | 0.29 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is 10.26% and Return on Invested Capital is 6.57%.
| Return on Equity | 10.26% |
| Return on Assets | 6.94% |
| Return on Invested Capital | 6.57% |
| Revenue Per Employee | $1,275,520.06 |
| Profits Per Employee | $136,361 |
| Employee Count | 723 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 12.01 |
Taxes
| Income Tax | 12.01M |
| Effective Tax Rate | 10.86% |
Stock Price Statistics
The stock price has increased by 28.42% in the
last 52 weeks. The beta is 0.31, so iHuman's
price volatility has been higher than the market average.
| Beta | 0.31 |
| 52-Week Price Change | 28.42% |
| 50-Day Moving Average | 2.23 |
| 200-Day Moving Average | 1.85 |
| Relative Strength Index (RSI) | 59.91 |
| Average Volume (20 Days) | 81,826 |
Income Statement
In the last 12 months, iHuman had revenue of 922.2M
and earned 98.59M
in profits. Earnings per share was 1.9.
| Revenue | 922.2M |
| Gross Profit | 640.15M |
| Operating Income | 71.91M |
| Net Income | 98.59M |
| EBITDA | 85.57M |
| EBIT | 71.91M |
| Earnings Per Share (EPS) | 1.9 |
Full Income StatementBalance Sheet
The company has 1.12B in cash and 14.91M in
debt, giving a net cash position of 1.11B.
| Cash & Cash Equivalents | 1.12B |
| Total Debt | 14.91M |
| Net Cash | 1.11B |
| Retained Earnings | -42.1M |
| Total Assets | 1.42B |
| Working Capital | 888.27M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 58.55M
and capital expenditures -7.45M, giving a free cash flow of 51.1M.
| Operating Cash Flow | 58.55M |
| Capital Expenditures | -7.45M |
| Free Cash Flow | 51.1M |
| FCF Per Share | 0.2 |
Full Cash Flow StatementMargins
Gross margin is 69.42%, with operating and profit margins of 7.8% and 10.69%.
| Gross Margin | 69.42% |
| Operating Margin | 7.8% |
| Pretax Margin | 11.99% |
| Profit Margin | 10.69% |
| EBITDA Margin | 9.28% |
| EBIT Margin | 7.8% |
| FCF Margin | 5.54% |
